New Generation of Meso and Antiprogestins (SPRMs) into the Osteoporosis Approach
Receptor activator of nuclear factor κB (RANK) and its ligand (RANKL) play key roles in bone metabolism and the immune system. The RANK/RANKL complex has also been shown to be critical in the formation of mammary epithelia cells. The female hormones estradiol and progesterone closely control the act...
Saved in:
Main Authors: | Magdalena Woźniczka, Katarzyna Błaszczak-Świątkiewicz |
---|---|
Format: | article |
Language: | EN |
Published: |
MDPI AG
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/7b10aaf7ac6e4049a35883c746c27a12 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Receptor activator of nuclear factor-κB ligand and osteoprotegerin: maintaining the balance to prevent bone loss
by: Anne-Priscille Trouvin, et al.
Published: (2010) -
Emerging treatments for postmenopausal osteoporosis – focus on denosumab
by: Piet Geusens
Published: (2009) -
Comprehensive Transcriptomic Profiling of Murine Osteoclast Differentiation Reveals Novel Differentially Expressed Genes and LncRNAs
by: Salman M. Toor, et al.
Published: (2021) -
Enfrentamiento de la osteoporosis post menopáusica en la consulta ginecológica
by: Francisco,Fuentes Q, et al.
Published: (2017) -
Changes in Bone Metabolism and Structure in Primary Hyperparathyroidism
by: Yankova I., et al.
Published: (2020)